重症脓毒症患者活性肾素水平与死亡率的相关性:VICTAS 试验的事后分析
该研究为 VICTAS 随机对照试验的事后分析,纳入美国 43 家医院 103 例脓毒症患者的生物样本,检测第 0 天和第 3 天的肾素-血管紧张素系统(RAS)指标。高基线活性肾素(中位数 188.7 pg/mL 分层)与 30 天死亡率升高相关(HR 2.84,95%CI 1.10-7.33,p=0.031;趋势 p=0.023)。第 0 天至第 3 天肾素每升高 1 个标准差(593.6 pg/mL),死亡风险增加(HR 3.75,95%CI 1.94-7.22,p<0.001);肾素下降者生存改善(HR 0.22,95%CI 0.08-0.60,p=0.003)。Ang-(1-7)、ACE2 活性、Ang-II 和 ACE 活性未见此关联。提示连续监测活性肾素可能有助于脓毒症风险分层。
要点
- 基线活性肾素高于中位数 188.7 pg/mL 的脓毒症患者,30 天死亡风险升高(HR 2.84,95%CI 1.10-7.33,p=0.031)。
- 基线活性肾素按四分位分组,Q4 与 Q1 相比死亡风险升高(HR 5.58,95%CI 1.18-26.32),线性趋势 p=0.023。
- 第 0 天至第 3 天肾素每升高 1 个标准差(593.6 pg/mL),30 天死亡风险增加(HR 3.75,95%CI 1.94-7.22,p<0.001)。
- 第 0 天至第 3 天肾素下降者较上升者生存改善(HR 0.22,95%CI 0.08-0.60,p=0.003)。
- 第 0 天肾素高于中位数者接受 VICTAS 干预后死亡率有所降低(交互作用 p=0.020),第 3 天未达统计学显著(交互作用 p=0.137)。
适用人群与场景
- VICTAS 随机对照试验纳入的脓毒症患者,有生物样本库样本者 103 例。
- 样本采集时间为第 0 天(呼吸衰竭或脓毒症休克后 24 小时内)和第 3 天。
诊断标准与关键阈值
- 活性肾素以中位数 188.7 pg/mL 二分类,高于中位数为高肾素组。
- 活性肾素按四分位分组:Q1 为参照,Q2、Q3、Q4 依次升高。
研究设计与关键结果
- 研究类型:VICTAS 随机对照试验的事后分析,纳入美国 43 家医院 103 例脓毒症患者的生物样本库样本,第 0 天样本 103 例,第 3 天样本 95 例。
- 主要终点:高基线活性肾素(中位数 188.7 pg/mL 二分类)与 30 天死亡率升高相关(HR 2.84,95%CI 1.10-7.33,p=0.031)。
- 基线活性肾素按四分位分组:Q1 为参照,Q2 HR 2.01(95%CI 0.37-11.04),Q3 HR 3.22(95%CI 0.64-16.28),Q4 HR 5.58(95%CI 1.18-26.32),线性趋势 p=0.023。
- 第 0 天至第 3 天肾素每升高 1 个标准差(593.6 pg/mL),30 天死亡风险增加(HR 3.75,95%CI 1.94-7.22,p<0.001)。
- 肾素下降者较肾素上升者生存改善(HR 0.22,95%CI 0.08-0.60,p=0.003)。
- Ang-(1-7)、ACE2 活性、Ang-II 和 ACE 活性与 30 天死亡率无此关联。
- 第 0 天肾素高于中位数者接受 VICTAS 干预后死亡率有所降低(交互作用 p=0.020),第 3 天未达统计学显著(交互作用 p=0.137)。
证据类型、等级与局限
- 证据类型:随机对照试验的事后分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 基线及第 3 天活性肾素可能有助于脓毒症患者 30 天死亡风险分层,高肾素及肾素上升者风险更高。
- 第 0 天肾素高于中位数患者接受 VICTAS 干预后死亡率有所降低(交互作用 p=0.020),第 3 天未达统计学显著(交互作用 p=0.137),原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: Sepsis is a leading cause of mortality. Predicting outcomes is challenging and few biomarkers perform well. Defects in the renin-angiotensin system (RAS) can predict clinical outcomes in sepsis and may outperform traditional biomarkers. We postulated that RAS dysfunction (elevated active renin, angiotensin 1-7 [Ang-(1-7)], and angiotensin-converting enzyme 2 (ACE2) activity with depressed Ang-II and ACE activity) would be associated with mortality in a cohort of septic patients.
DESIGN: Post hoc analysis of patients enrolled in the Vitamin C, Thiamine, and Steroids in Sepsis (VICTAS) randomized controlled trial.
SETTING: Forty-three hospitals across the United States.
PATIENTS: Biorepository samples of 103 patients.
INTERVENTIONS: We analyzed day 0 (within 24 hr of respiratory failure, septic shock, or both) and day 3 samples ( n = 103 and 95, respectively) for assessment of the RAS. The association of RAS values with 30-day mortality was determined using Cox proportional hazards regression with multivariable adjustments for age, sex, VICTAS treatment arm, systolic blood pressure, Sequential Organ Failure Assessment Score, and vasopressor use.
MEASUREMENTS AND MAIN RESULTS: High baseline active renin values were associated with higher 30-day mortality when dichotomized to the median of 188.7 pg/mL (hazard ratio [HR] = 2.84 [95% CI, 1.10-7.33], p = 0.031) or stratified into quartiles (Q1 = ref, HR Q2 = 2.01 [0.37-11.04], HR Q3 = 3.22 [0.64-16.28], HR Q4 = 5.58 [1.18-26.32], p for linear trend = 0.023). A 1- sd (593.6 pg/mL) increase in renin from day 0 to day 3 was associated with increased mortality (HR = 3.75 [95% CI, 1.94-7.22], p < 0.001), and patients whose renin decreased had improved survival compared with those whose renin increased (HR 0.22 [95% CI, 0.08-0.60], p = 0.003). Ang-(1-7), ACE2 activity, Ang-II and ACE activity did not show this association. Mortality was attenuated in patients with renin over the median on day 0 who received the VICTAS intervention, but not on day 3 ( p interaction 0.020 and 0.137, respectively). There were no additional consistent patterns of mortality on the RAS from the VICTAS intervention.
CONCLUSIONS: Baseline serum active renin levels were strongly associated with mortality in critically ill patients with sepsis. Furthermore, a greater relative activation in circulating renin from day 0 to day 3 was associated with a higher risk of death.
参考来源
- Busse LW, Schaich CL, Chappell MC, et al. Association of Active Renin Content With Mortality in Critically Ill Patients: A Post hoc Analysis of the Vitamin C, Thiamine, and Steroids in Sepsis (VICTAS) Trial. Crit Care Med. 2023. PMID: 37947484. doi:10.1097/CCM.0000000000006095
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。